---
document_datetime: 2024-01-17 11:30:01
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/prasugrel-viatris-previously-prasugrel-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: prasugrel-viatris-previously-prasugrel-mylan-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 8.9432521
conversion_datetime: 2025-12-28 18:05:28.074617
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Prasugrel Viatris

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                    | Opinion/ Notification 1 issued on   | Commission Decision Issued² / amended on   | Product Information affected3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| IG/1688              | A.2.a-Administrative change -Change in the (invented)nameofthemedicinalproductforCAPs    | 15/01/2024                          |                                            | SmPC, Labelling and PL          |           |
| N/0016               | Minor change inlabelling orpackageleafletnot connected with theSPC(Art.61.3Notification) | 15/09/2023                          |                                            | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0015/G R/0014   | This was an applicationfor a group ofvariations. A.5.b-Administrative change-Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excludingmanufacturerforbatchrelease) A.7-Administrative change-Deletion of manufacturing sites Renewalofthemarketingauthorisation.   | 29/05/2023 26/01/2023   | n/a 20/03/2023   | SmPC and PL   | Based on the review of data on quality, safety and efficacy, theCHMPconsidered thatthebenefit-riskbalanceof Prasugrel Mylanintheapprovedindicationremains favourableandthereforerecommendedtherenewalofthe marketing authorisation with unlimited validity.   |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------|------------------|---------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0013            | B.I.z-Quality change-Active substance-Other variation                                                                                                                                                                                                                                                                                     | 15/09/2022              | n/a              |               |                                                                                                                                                                                                                                                               |
| IA/0012            | A.4 - Administrative change - Change in the name and/oraddressofamanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateused in themanufactureof theASor manufacturerofanovelexcipient                                                                                                                       | 22/06/2022              | n/a              |               |                                                                                                                                                                                                                                                               |
| IAIN/0011          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                        | 31/05/2022              | n/a              |               |                                                                                                                                                                                                                                                               |
| N/0010             | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3Notification)                                                                                                                                                                                                                                                     | 25/05/2022              | 09/01/2023       | PL            |                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

|         | B.II.f.1.a.1-Stability of FP-Reduction of the shelf lifeof thefinishedproduct-Aspackagedforsale                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 22/12/2021   | 09/01/2023   | SmPC                             | IB/0009   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|-----------|
| T/0008  | TransferofMarketingAuthorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 15/09/2021   | 19/10/2021   | SmPC, Labelling and PL           |           |
| IA/0007 | A.7-Administrative change-Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 11/01/2021   | n/a          |                                  |           |
| IB/0006 | B.II.f.1.b.1-StabilityofFP-Extensionof theshelf lifeof thefinishedproduct-Aspackagedforsale (supportedbyreal time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 25/11/2020   | 19/10/2021   | SmPC and PL                      |           |
| IB/0005 | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supportedbyreal time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 04/03/2020   | 15/09/2020   | SmPC and PL                      |           |
|         | Thiswas an applicationfor a groupof variations. B.II.d.1.z-Change in the specification parameters and/orlimitsof thefinishedproduct-Othervariation B.II.e.1.b.1-Change in immediate packaging of the finished product - Change in type/addition of a new container - Solid, semi-solid and non-sterile liquid pharmaceuticalforms B.II.e.1.b.1 - Change in immediate packaging of the finished product - Change in type/addition of a new container-Solid, semi-solid and non-sterile liquid pharmaceuticalforms B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. | 12/09/2019   | 15/09/2020   | SmPC, Annex II, Labelling and PL | I1/0003/G |

<div style=\"page-break-after: always\"></div>

tablets, ampoules,etc.)in a pack-Change within the range of the currently approved pack sizes B.II.e.5.a.1-Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within therange of the currently approvedpack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within therangeofthecurrentlyapprovedpacksizes B.II.e.5.a.1-Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.)in a pack-Change within therangeofthecurrentlyapprovedpacksizes B.II.e.5.a.1-Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within therangeof thecurrentlyapprovedpacksizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack -Change outside the range of the currently approved pack sizes B.II.e.5.a.2-Change in pack size of the finished product - Change in the number of units (e.g.

<div style=\"page-break-after: always\"></div>

|           | tablets,ampoules,etc.)in a pack-Change outside the range of the currently approved pack sizes                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |            |            |                        |           |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------|
| IAIN/0004 | B.II.b.1.a-Replacement or addition of a manufacturing site for the Fp - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 25/03/2019 | n/a        |                        |           |
| IB/0002   | C.I.2.a -Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                                                                                                                                         | 09/01/2019 | 26/08/2019 | SmPC and PL            | the MAH   |
|           | This was an application for a group of variations. B.II.f.1.b.1-Stability of FP -Extension of the shelf lifeof thefinishedproduct-Aspackagedforsale (supported by real time data) B.II.e.5.a.2-Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.)in a pack-Change outside therangeofthecurrentlyapprovedpacksizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 03/09/2018 | 26/08/2019 | SmPC, Labelling and PL | IB/0001/G |